Human Genome Epidemiology Literature Finder
|
Records 1 - 13 (of 13 Records) |
| Query Trace: Disease Progression and meta-analysis and EGFR[original query] |
|---|
| Combination of EGFR-TKIs and chemotherapy as first-line therapy for advanced NSCLC: a meta-analysis. PloS one 2013 8 (11): e79000. OuYang Pu-Yun, Su Zhen, Mao Yan-Ping, Deng Wuguo, Xie Fang-Y |
| Anti-epidermal growth factor receptor monoclonal antibody-based therapy for metastatic colorectal cancer: a meta-analysis of the effect of PIK3CA mutations in KRAS wild-type patients. Archives of medical science : AMS 2014 Feb 10 (1): 1-9. Huang Lulu, Liu Zhenfang, Deng Donghong, Tan Aihua, Liao Ming, Mo Zengnan, Yang Xiao |
| Gefitinib or Erlotinib vs Chemotherapy for EGFR Mutation-Positive Lung Cancer: Individual Patient Data Meta-Analysis of Overall Survival. Journal of the National Cancer Institute 2017 Jun 109 (6): . Lee Chee Khoon, Davies Lucy, Wu Yi-Long, Mitsudomi Tetsuya, Inoue Akira, Rosell Rafael, Zhou Caicun, Nakagawa Kazuhiko, Thongprasert Sumitra, Fukuoka Masahiro, Lord Sally, Marschner Ian, Tu Yu-Kang, Gralla Richard J, Gebski Val, Mok Tony, Yang James Chih-Hs |
| A meta-analysis of the comparing of the first-generation and next-generation TKIs in the treatment of NSCLC. Mathematical biosciences and engineering : MBE 2019 9 16 (5): 5687-5696. Li Yong Xing, Yang Jian Ye, Xu Yu Fen, Zhang Ming, Zhang Xiao Ping, Chen Wen Yu, Lv Xiao Do |
| The impact of epidermal growth factor receptor mutations on the efficacy of definitive chemoradiotherapy in patients with locally advanced unresectable stage III non-small cell lung cancer: a systematic review and meta-analysis. Expert review of anticancer therapy 2019 May . Qin Qin, Peng Bing, Li Baoshe |
| Prevalence of RAS and BRAF mutations in metastatic colorectal cancer patients by tumor sidedness: A systematic review and meta-analysis. Cancer medicine 2019 Dec . Bylsma Lauren C, Gillezeau Christina, Garawin Tamer A, Kelsh Michael A, Fryzek Jon P, Sangaré Laura, Lowe Kimberly |
| Plasma ctDNA RAS status selects patients for anti-EGFR treatment rechallenge in metastatic colorectal cancer: a meta-analysis. Experimental oncology 2021 09 43 (3): 252-256. Vlachou M S, Mauri D, Zarkavelis G, Ntellas P, Tagkas C, Gkoura S, Pentheroudakis |
| Rational Application of First-Line EGFR-TKIs Combined with Antiangiogenic Inhibitors in Advanced EGFR-Mutant Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis. BioMed research international 2021 8850256. Ma Jie-Tao, Guo Yi-Jia, Song Jun, Sun Li, Zhang Shu-Ling, Huang Le-Tian, Jing Wei, Zhao Jian-Zhu, Han Cheng- |
| Should We Perform Repeated Re-Biopsy for the Detection of T790M Mutation? Cancer research and treatment 2023 4 . Saerom Kim, Soo Han Kim, Jinmi Kim, Mi-Hyun Kim, Min Ki Lee, Jung Seop E |
| Influence of Smoking Habits on the Efficacy of EGFR-TKI Therapy in Patients with Advanced NSCLC: A Systematic Review and Meta-Analysis. Clinical Medicine Insights. Oncology 2023 12 17 11795549231215968. Zexun Mo, Meifeng Ye, Hua He, Xiaomei Huang, Weihong Guo, Ziwen Zhao, Yujun Li, Shuquan W |
| Immunotherapy plus chemotherapy for patients with EGFR-mutated non-squamous cell lung cancer for disease progression after EGFR tyrosine-kinase inhibitor: A meta-analysis of randomized controlled trials. Oncology 2024 9 1-26. Ahmed A Refae, Rafat I Abu Shakra, Ezzeldin M Ibrah |
| Comparison of treatment regimens for unresectable stage III epidermal growth factor receptor (EGFR) mutant non-small cell lung cancer. Chinese medical journal 2024 12 . Xin Dai, Qian Xu, Lei Sheng, Xue Zhang, Miao Huang, Song Li, Kai Huang, Jiahui Chu, Jian Wang, Jisheng Li, Yanguo Liu, Jianyuan Zhou, Shulun Nie, Lian L |
| Efficacy of Adjuvant First-Generation TKIs versus Chemotherapy in Patients with Completely Resected EGFR-Mutant Non-Small Cell Lung Cancer: A Meta-Analysis. Cancer investigation 2024 1 1-12. Bin Shen, Dongping Wu, Jianjiang Liu, Yang Ya |
- Page last reviewed:Feb 1, 2024
- Content source: